In the absence of FGL2 we observed increased T cells (CD3+) overall in ID8-p53−/−Brca2−/− tumours (Fig. S9A) and the CD4+ T cells showed a trend (p = 0.06) for higher expression of TIGIT (Fig. S9B). This evidence concerns the gene FGL2 and neoplasm.